Author(s): Ishibashi K, Tokumoto T, Shirakawa H, Oguro T, Yanagida T,
Abstract Share this page
Abstract The aim of this study was to evaluate the association between antibodies against cytomegalovirus (CMV) glycoprotein B (gB) and acute rejection after transplantation. Seventy-seven consecutive renal transplant recipients in a D + /R+ setting were studied. Biopsy-proven rejection occurred in 35\% of the recipients. Among these recipients, 85\% had antibodies against CMV gB. The rate of acute rejection was significantly higher in recipients with antibodies against gB than in those without them. Antibodies against gB can be a useful predictor of acute rejection in renal transplant recipients in a D + /R+ setting. © 2013 The Societies and Wiley Publishing Asia Pty Ltd.
This article was published in Microbiol Immunol
and referenced in Journal of Metabolic Syndrome